← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 1993Last known activity
Oct 31, 2019
Timeline
1950s
- Jan 1, 1952
Los Angeles Biomedical Research Institute— Founded
Drugs by trial phase (73 distinct, 56 trials)
Phase 4 (17 own, 0 via acquisition)
Phase 3 (13 own, 0 via acquisition)
Phase 2 (14 own, 0 via acquisition)
Phase 1 (12 own, 0 via acquisition)
Other trials (17 own, 0 via acquisition)
Indications
Studied for
- Acute Pain
- Anemia
- Anemia, Sickle Cell
- Anxiety Disorders
- Arthritis, Infectious
- Atherosclerosis
- Atrial Fibrillation
- Autistic Disorder
- Blindness
- Calcinosis
- Cellulitis
- Chronic Pain
- Communicable Diseases
- Corneal Ulcer
- Coronary Artery Disease
- Coronary Stenosis
- Eye Injuries
- Familial Primary Pulmonary Hypertension
- Fatigue
- Headache
- Heart Diseases
- Hepatitis
- Hepatitis A
- Hepatitis, Alcoholic
- Hypertension
- Hypoalbuminemia
- Hypogonadism
- Infections
- Inflammation
- Insulin Resistance
- Intermittent Claudication
- Keratitis
- Kidney Diseases
- Lung Diseases
- Lung Diseases, Obstructive
- Malnutrition
- Metabolic Syndrome
- Migraine Disorders
- Mucopolysaccharidoses
- Mucopolysaccharidosis I
- Mucopolysaccharidosis II
- Mucopolysaccharidosis III
- Mucopolysaccharidosis VI
- Mucormycosis
- Myocardial Ischemia
- Night Blindness
- Osteopetrosis
- Peripheral Arterial Disease
- Protein-Energy Malnutrition
- Pulmonary Disease, Chronic Obstructive
- Renal Insufficiency, Chronic
- Sepsis
- Skin Diseases, Infectious
- Soft Tissue Infections
- Staphylococcal Infections
- Surgical Wound Infection
- Thalassemia
- Toxemia
- Ulcer
- Vascular Diseases
- Vitamin A Deficiency
- Zygomycosis
Recent trials (50)
- NCT04067856Lead sponsorN/AOct 31, 2019
- NCT04067856Reponsible party - principal investigatorN/AOct 31, 2019
- NCT04018755Overall official - principal investigatorPhase 2/Phase 3Sep 30, 2019
- NCT04018755Lead sponsorPhase 2/Phase 3Sep 30, 2019
- NCT04037605Overall official - principal investigatorEarly Phase 1Jul 24, 2019
- NCT04037605Lead sponsorEarly Phase 1Jul 24, 2019
- NCT03985384Reponsible party - principal investigatorPhase 4Apr 30, 2019
- NCT03985384Lead sponsorPhase 4Apr 30, 2019
- NCT03906825Lead sponsorN/AMay 17, 2018
- NCT03906825Reponsible party - principal investigatorN/AMay 17, 2018
- NCT03455075CollaboratorPhase 2Apr 16, 2018
- NCT03909789Lead sponsorN/ANov 17, 2017
- NCT03909789Reponsible party - principal investigatorN/ANov 17, 2017
- NCT03298373CollaboratorPhase 1Nov 9, 2017
- NCT03206723Lead sponsorPhase 2Jul 1, 2017
Details
- Founded
- Los Angeles, CA, US Jan 1, 1952
- Last known activity
- Oct 31, 2019
Notes
non-profit research institute